Systeme, Vorrichtungen und Verfahren zur Drahtlosen Kommunikation in Analytüberwachungsvorrichtungen
Anmelder: Abbott Diabetes Care Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4716273
- Anmeldetag
- 18. Dezember 2017
- Veröffentlichung
- 25. März 2026
- Rechtsraum
- EP
- IPC
- H04W12/50(ULRICH ROBERT R et al.)(LINN CHRISTOPHER S et al.)(NEC CORP et al.)
Abstract
Systems, devices and methods are provided that allow for enhanced performance, power efficiency, interoperability, data security and user privacy for in vivo analyte monitoring systems that utilize wireless communications. The in vivo analyte monitoring systems can include a Bluetooth or Bluetooth Low Energy enabled handheld relay device for wirelessly relaying analyte data between a sensor unit device and one or more reader devices. The in vivo analyte monitoring systems can employ advertisement and encryption schemes for wirelessly transmitting data in a manner that allows for improved security, efficiency and privacy.
Anmelder
- Firma
- Abbott Diabetes Care Inc.
- Land
- 🇺🇸 USA
US-amerikanisches Gesundheitsunternehmen mit Sitz in Illinois, aktiv in Diagnostik, Medizintechnik, Ernährung und Pharmazeutika.
2.821 Patente in unserer Datenbank
Vertreten von
-
Mathys & Squire
Mathys & Squire · München